Dubois-Stringfellow Nathalie
SVP-CHIEF DEVELOPMENT OFFICER
Dubois-Stringfellow Nathalie has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: May 27, 2026.
On the most recent filing, Dubois-Stringfellow Nathalie is listed as SVP-CHIEF DEVELOPMENT OFFICER at SANGAMO THERAPEUTICS, INC. Inside the rolling window, Dubois-Stringfellow Nathalie reported no open-market purchases and 1 open-market sale totaling $89K in SGMO.
Companies traded
Other insiders at SGMO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$89K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Dubois-Stringfellow Nathalie made?
Dubois-Stringfellow Nathalie has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Dubois-Stringfellow Nathalie trade?
Dubois-Stringfellow Nathalie has filed SEC Form 4 disclosures for 1 company, including SGMO.
When was Dubois-Stringfellow Nathalie's most recent SEC Form 4 filing?
Dubois-Stringfellow Nathalie's most recent SEC Form 4 filing on Tracefour is dated May 27, 2026.
What is Dubois-Stringfellow Nathalie's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Dubois-Stringfellow Nathalie is listed as SVP-CHIEF DEVELOPMENT OFFICER.
What is Dubois-Stringfellow Nathalie's total buy and sell value in the current window?
Inside the rolling retention window, Dubois-Stringfellow Nathalie bought $0 and sold $89K based on SEC Form 4 filings.
What was Dubois-Stringfellow Nathalie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 345,942 SGMO shares on 2026-04-21, worth $89K, per SEC Form 4 filings.